Related Experiment Video

Updated: Oct 10, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

M Terabe1, S Matsui, N Noben-Trauth

  • 1Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Nature Immunology
|March 23, 2001
PubMed

Insights

Interleukin-13 (IL-13) and natural killer T (NKT) cells drive tumor recurrence by suppressing immune surveillance. Inhibiting IL-13 may enhance cancer immunotherapy effectiveness.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Cytotoxic T lymphocyte (CTL)-mediated immunosurveillance is crucial for controlling tumor growth.
  • Tumor recurrence suggests a failure in maintaining anti-tumor immune responses.
  • Understanding mechanisms of immune evasion is vital for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the down-regulation of tumor immunosurveillance leading to tumor recurrence.
  • To identify key cytokines and immune cells involved in overcoming CTL-mediated tumor rejection.

Main Methods:

  • Utilized a mouse model exhibiting tumor growth-regression-recurrence.
  • Employed knockout mouse models for interleukin 4 receptor (IL-4R), signal transducer and activator of transcription 6 (STAT6), and IL-4.
  • Administered an IL-13 inhibitor (sIL-13R alpha 2-Fc) and used CD1 knockout mice lacking natural killer T (NKT) cells.

Main Results:

  • IL-4R and STAT6 knockout mice, but not IL-4 knockout mice, resisted tumor recurrence, implicating IL-13.
  • IL-13 inhibition also prevented tumor recurrence.
  • Loss of NKT cells led to reduced IL-13 production and resistance to tumor recurrence.

Conclusions:

  • NKT cells and IL-13 signaling through the IL-4R-STAT6 pathway are critical for suppressing tumor immunosurveillance and promoting recurrence.
  • IL-13 acts as a key mediator in tumor immune evasion.
  • Targeting IL-13 with inhibitors presents a promising strategy for enhancing cancer immunotherapy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...